Nolan-Patrick Cunningham

Calibration of Multisite Raters for Prospective Visual Reads of Amyloid PET Scans (Soleimani-Meigooni et al., 2025)

Citation : Soleimani-Meigooni, D. N., Pezzoli, S., Blazhenets, G., La Joie, R., Lin, Z., Soppe, C. L., Johnson, D. R., Koran, M. E. I., McConathy, J. E., Nasrallah, I. M., Ponisio, M. R., Tanner, J. A., Villemagne, V. L., Windon, C. C., Zeineh, M., Biber, S., Kukull, W. A., O’Connell, H., Peterson, D. J., … […]

Calibration of Multisite Raters for Prospective Visual Reads of Amyloid PET Scans (Soleimani-Meigooni et al., 2025) Read More »

The PREVENT-AD cohort: Accelerating Alzheimer’s disease research and treatment in Canada and beyond (Villeneuve et al., 2025)

Citation : Villeneuve, S., Poirier, J., Breitner, J. C., Tremblay‐Mercier, J., Remz, J., Raoult, J., Yakoub, Y., Gallego‐Rudolf, J., Qiu, T., Fajardo Valdez, A., Mohammediyan, B., Javanray, M., Metz, A., Sanami, S., Ourry, V., Wearn, A., Pastor‐Bernier, A., Edde, M., Gonneaud, J., … PREVENT-AD Research Group. (2025). The prevent‐AD cohort: Accelerating alzheimer’s disease research and

The PREVENT-AD cohort: Accelerating Alzheimer’s disease research and treatment in Canada and beyond (Villeneuve et al., 2025) Read More »

Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease: Role of Sex and Parent’s Sex (Ourry et al., 2025)

Citation : Ourry, V., Fajardo-Valdez, A., Soucy, J.-P., Poirier, J., Breitner, J. C. S., Villeneuve, S., & PREVENT-AD Research Group. (2025). Amyloid and tau pathology in cognitively unimpaired individuals with a parental history of alzheimer disease: Role of sex and parent’s sex. Neurology, 104(9). https://doi.org/10.1212/wnl.0000000000213507 Full text : Here Amyloid and Tau Pathology in Cognitively

Amyloid and Tau Pathology in Cognitively Unimpaired Individuals With a Parental History of Alzheimer Disease: Role of Sex and Parent’s Sex (Ourry et al., 2025) Read More »

Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease (Sanami et al., 2025)

Citation : Sanami, S., Intzandt, B., Huck, J., Villeneuve, S., Iturria-Medina, Y., Gauthier, C. J., & PREVENT-AD Research Group (2025). Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease. Neurobiology of aging, 152, 43–53. https://doi.org/10.1016/j.neurobiolaging.2025.04.011 Full text : Here Longitudinal Relationships Among Cerebrospinal Fluid

Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer’s disease (Sanami et al., 2025) Read More »

Differential effects of aging, Alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults (Fischer et al., 2025)

Citation : Fischer, L., Adams, J. N., Molloy, E. N., Vockert, N., Tremblay-Mercier, J., Remz, J., Pichet Binette, A., Villeneuve, S., Maass, A., & PREVENT-AD Research Group. (2025). Differential effects of aging, alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults. Alzheimer’s Research & Therapy, 17(1). https://doi.org/10.1186/s13195-025-01742-6 Full text :

Differential effects of aging, Alzheimer’s pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults (Fischer et al., 2025) Read More »

Plasma p-Tau217 and Tau-PET Predict Future Cognitive Decline Among Cognitively Unimpaired Individuals: Implications for Clinical Trials (Ossenkoppele et al., 2025)

Citation : Ossenkoppele, R., Salvadó, G., Janelidze, S., Pichet Binette, A., Bali, D., Karlsson, L., Palmqvist, S., Mattsson-Carlgren, N., Stomrud, E., Therriault, J., Rahmouni, N., Rosa-Neto, P., Coomans, E. M., van de Giessen, E., van der Flier, W. M., Teunissen, C. E., Jonaitis, E. M., Johnson, S. C., Villeneuve, S., … Hansson, O. (2025). Plasma

Plasma p-Tau217 and Tau-PET Predict Future Cognitive Decline Among Cognitively Unimpaired Individuals: Implications for Clinical Trials (Ossenkoppele et al., 2025) Read More »

Tau PET Positivity in Individuals With and Without Cognitive Impairment Varies with Age, Amyloid-β Status, APOE Genotype and Sex (Ossenkoppele et al., 2025)

Citation : Ossenkoppele, R., Coomans, E. M., Apostolova, L. G., Baker, S. L., Barthel, H., Beach, T. G., Benzinger, T. L., Betthauser, T., Bischof, G. N., Bottlaender, M., Bourgeat, P., den Braber, A., Brendel, M., Brickman, A. M., Cash, D. M., Carrillo, M. C., Coath, W., Christian, B. T., Dickerson, B. C., … Hansson, O.

Tau PET Positivity in Individuals With and Without Cognitive Impairment Varies with Age, Amyloid-β Status, APOE Genotype and Sex (Ossenkoppele et al., 2025) Read More »

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease (Gonzalez-Ortiz et al., 2025)

Citation : Gonzalez-Ortiz, F., Kirsebom, B.-E., Yakoub, Y., Gundersen, J. K., Pålhaugen, L., Waterloo, K., Selnes, P., Jarholm, J. A., Gísladóttir, B., Rongve, A., Skogseth, R. E., Bråthen, G., Aarsland, D., Turton, M., Harrison, P., Zetterberg, H., Villeneuve, S., Fladby, T., & Blennow, K. (2025). Associations between changes in levels of phosphorylated tau and severity

Associations Between Changes in Levels of Phosphorylated Tau and Severity of Cognitive Impairment in Early Alzheimer Disease (Gonzalez-Ortiz et al., 2025) Read More »

Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression (Picard et al., 2025)

Citation : Picard, C., Zetterberg, H., Blennow, K., Villeneuve, S., Poirier, J., & on behalf of the PREVENT-AD Research Group. (2025). Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression. Genes, 16(7), 818. https://doi.org/10.3390/genes16070818 Full text : Here Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression Cynthia Picard, Henrik Zetterberg,

Brain and CSF Alzheimer’s Biomarkers Are Associated with SERPINE1 Gene Expression (Picard et al., 2025) Read More »